Becton Dickinson (BDX) vs Glaukos (GKOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Glaukos (GKOS) has outperformed Becton Dickinson (BDX) over the past year, gaining 138.2% versus a gain of 40.4%. Over five years, GKOS leads with a +421.6% price change compared with +13.2% for BDX. Becton Dickinson is the larger company by market cap ($57.96 billion vs $14.05 billion), about 4.1 times the size, while Glaukos is growing revenue faster (+32.3% vs +8.2%).
On valuation, Becton Dickinson trades at a lower forward P/E (15.0x vs 169.5x for Glaukos). Becton Dickinson converts more of its revenue into profit, with a net margin of 7.7% versus -37.0%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BDX | GKOS |
|---|---|---|
| Share price | $212.78 | $237.31 |
| Market cap | $57.96B | $14.05B |
| 1-day change | +0.05% | -0.33% |
| YTD return | +39.46% | +110.18% |
| 1-year return | +40.44% | +138.22% |
| 5-year return | +13.19% | +421.56% |
| P/E ratio (TTM) | 42.05 | — |
| Forward P/E | 14.96 | 169.50 |
| EPS (TTM) | $5.06 | $-2.95 |
| Dividend yield | 1.99% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $21.84B | $507.44M |
| Revenue growth (YoY) | +8.24% | +32.33% |
| Net income (latest FY) | $1.68B | $-187.69M |
| Gross margin | 45.44% | 55.72% |
| Operating margin | 11.81% | -39.33% |
| Net margin | 7.68% | -36.99% |
| 52-week high | $220.36 | $255.19 |
| 52-week low | $140.11 | $93.96 |
| Distance from 52-week high | -3.44% | -7.00% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +6.28% | +2.76% |
| Average volume | 1.80M | 1.19M |
| Shares outstanding | 272.39M | 59.20M |
| Employees | 60,000 | 1,094 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Becton Dickinson is about 4.1 times larger than Glaukos by market value ($57.96B vs $14.05B).
- GKOS has outperformed BDX by 97.8 percentage points over the past year.
- Becton Dickinson offers a meaningfully higher dividend yield (1.99% vs 0.00%).
- Becton Dickinson is more profitable, keeping 7.7 cents of every revenue dollar as net income versus -37.0 cents for Glaukos.
- Glaukos grew revenue faster in its latest fiscal year (+32.33% vs +8.24%).
About Becton Dickinson
BDX stock →Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments.
Health Care · Medical/Dental Instruments · 60,000 employees
About Glaukos
GKOS stock →Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.
Health Care · Medical/Dental Instruments · 1,094 employees
BDX vs GKOS FAQ
Which is bigger, Becton Dickinson or Glaukos?
Becton Dickinson (BDX) is larger, with a market capitalization of $57.96B compared with $14.05B for Glaukos (GKOS).
Which stock has performed better over the past year, BDX or GKOS?
GKOS returned +138.22% over the past 12 months, compared with +40.44% for BDX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Becton Dickinson or Glaukos?
Becton Dickinson pays a dividend yielding 1.99%, while Glaukos does not currently pay a regular dividend.
Are Becton Dickinson and Glaukos in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.